Skip to main content
Elsevier
View Cart
openUserAccount

Books in Hematology

BooksJournals
81-90 of 106 results in All results

Haematology

  • 4th Edition
  • May 30, 2013
  • Martin R. Howard + 1 more
  • English
  • Paperback
    9 7 8 - 0 - 7 0 2 0 - 5 1 3 9 - 5
  • eBook
    9 7 8 - 0 - 7 0 2 0 - 5 4 1 5 - 0
2014 BMA Medical Book Awards Highly Commended in Internal Medicine category! This textbook on haematology in the Illustrated Colour Text series is suitable for medical students, junior doctors and others needing a concise and practical introduction to the subject.

Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America

  • 1st Edition
  • Volume 27-2
  • April 23, 2013
  • Jennifer R. Brown
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 7 1 0 1 - 1
  • eBook
    9 7 8 - 1 - 4 5 5 7 - 7 1 8 8 - 2
This issue of Hematology/Oncology Clinics is edited by Dr. Jennifer Brown and focuses on Chronic Lymphocytic Leukemia. Article topics include: What Have Recent Genomic Advances Taught us About CLL?, Biology of CLL in Different Microenvironments,What is the Significance of Stereotyped BCRs in CLL?, Understanding Immunodeficiency in CLL, MBL vs CLL: How Important is the Distinction?, Risk Stratification of CLL in 2012, Minimal Residual Disease Measurement in CLL, The BTK Inhibitor PCI-32765 in CLL, and Evolving Role of Stem Cell Transplantation in CLL.

Hematology: Diagnosis and Treatment E-Book

  • 6th Edition
  • March 29, 2013
  • Ronald Hoffman + 5 more
  • English
  • eBook
    9 7 8 - 1 - 4 5 5 7 - 7 6 8 8 - 7
The Hematology: Diagnosis and Treatment eBook is the ideal mobile resource in hematology! It distills the most essential, practical information from Hematology: Basic Principles and Practice, 6th Edition - the comprehensive masterwork by Drs. Hoffman, Benz, Silberstein, Heslop, Weitz, and Anastasi - into a concise, clinically focused resource that's optimized for reference on any e-reader. Focusing on the dependable, state-of-the-art clinical strategies you need to optimally diagnose and manage the full range of blood diseases and disorders, this eBook is a must-have for every hematologist's mobile device!

Neutropenia, An Issue of Hematology/Oncology Clinics of North America

  • 1st Edition
  • Volume 27-1
  • February 28, 2013
  • Christoph Klein
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 7 1 0 0 - 4
  • eBook
    9 7 8 - 1 - 4 5 5 7 - 7 1 8 7 - 5
This issue of Hematology/Oncology Clinics is guest edited by Dr. Christoph Klein and focuses on the topic of Neutropenia. Article titles include: Homeostasis and migration of neutrophil granulocytes,Granulocyte-colony Stimulating Factor (G-CSF) receptor signaling,New Granulocyte-colony Stimulating Factor (G-CSF) Receptor Signaling Pathways ,Neutrophil elastase (ELANE) – Genetics and Pathophysiology,Autosomal recessive variants of Severe congenital neutropenia (SCN),Leukocyte Adhesion Deficiency (LAD), and Genotype-phenotype correlations in Severe congenital neutropenia (SCN).

Quality Control in the age of Risk Management, An Issue of Clinics in Laboratory Medicine

  • 1st Edition
  • Volume 33-1
  • January 28, 2013
  • James O. Westgard + 1 more
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 7 1 1 0 - 3
  • eBook
    9 7 8 - 1 - 4 5 5 7 - 7 2 3 1 - 5
In October of 2011, CLSI published a new guideline EP23A on “Laboratory Quality Control Based on Risk Management.” In March, 2012, CMS announced its intention to incorporate key concepts from EP23A into its Interpretative Guidelines and QC policy for “Individualized Quality Control Plans.” Thus begins a new era of Quality Control in the Age of Risk Management. This issue is intended to help laboratories with the transition between traditional QC practices and the new risk management approach. Laboratories face a steep learning curve to apply risk analysis for identifying and prioritizing failure-modes, developing and implementing control mechanisms to detect those failure-modes, and assessing the acceptability of the residual risks that exist after implementation of a QC Plan. One of the main benefits of the new risk analysis based QC Plans should be an integration of all the control mechanisms that are needed to monitor the total testing process, including pre-analytic, analytic, and post-analytic controls. One of the main risks of the new approach is an expectation that Statistical QC is no longer important, even though SQC still remains the most useful and flexible approach for monitoring the quality of the analytic process. The key to the future is the successful integration of all these control mechanisms to provide a cost-effective quality system that monitors all phases of the total testing process. This issue should help laboratories understand the evolution of QC practices to include risk management, but also to recognize the need to maintain traditional techniques such as Statistical QC, especially during the transition to well-designed and carefully-validated QC Plans. Risk analysis may be risky business unless laboratories proceed carefully and cautiously.

Central Nervous System Malignancies, An Issue of Hematology/Oncology Clinics of North America

  • 1st Edition
  • Volume 26-4
  • July 18, 2012
  • Jill Lacy + 1 more
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 4 9 4 0 - 9
  • eBook
    9 7 8 - 1 - 4 5 5 7 - 4 7 6 3 - 4
Topics include: Neoplastic Meningitis and Epidural Metastases: Evaluation and Management; Management of Brain Metastases: Surgery, Radiation, or Both?; Meningiomas/Nerve Sheath Tumors/Pituitary Tumors: Diagnosis and Treatment; Medulloblastoma/Primitive Neuroectodermal Tumor and Germ Cell Tumors: The Uncommon but Potentially Curable Primary Brain Tumors; Primary CNS Lymphoma: Overview of Current Treatment Strategies; Anaplastic Gliomas: Radiation, Chemotherapy, or Both?; Low Grade Gliomas: When and How to Treat?; Glioblastoma Multiforme: Overview of Current Treatment and Future Perspectives.

New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America

  • 1st Edition
  • Volume 26-3
  • May 8, 2012
  • Franco Muggia
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 3 8 7 6 - 2
  • eBook
    9 7 8 - 1 - 4 5 5 7 - 4 4 0 8 - 4
Topics in this issue include: Targeting IGF-1R; Tyrosine Kinase Inhibitors in Lung Cancer; Targeting mTOR; Targeting Hedgehog; Mitotic Inhibitors; Topoisomerase I Inhibitors; and New Strategies and Drugs Inhibiting Folate Pathways.

Consultative Hematology, An Issue of Hematology/Oncology Clinics of North America

  • 1st Edition
  • Volume 26-2
  • April 23, 2012
  • Fred J. Schiffman + 1 more
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 3 8 7 5 - 5
  • eBook
    9 7 8 - 1 - 4 5 5 7 - 4 4 0 7 - 7
Topics in this issue include: Why does my patient have leukocytosis?; Why Is My Patient Neutropenic?; Does My Patient with a Serum Monoclonal Spike have Multiple Myeloma?; DVT and Pulmonary Embolism; Why Does My Patient Have Lymphadenopathy/Splenomegaly?; and Why Does My Patient have Thrombocytopenia?

Acute Leukemia, An Issue of Hematology/Oncology Clinics of North America

  • 1st Edition
  • Volume 25-6
  • December 15, 2011
  • Martin S. Tallman
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 1 1 9 7 - 0
Topics for this issue will include: CLL: A Historical Perspective; Incidence & Epidemiology; Biology, Molecular Biology & Cytogenetics of CLL; What does the status of smatic hypermutations in IGVH genes tell us about the origin of CLL?; What does the status of ZAP-70 tell us about the biology of CLL?; and Approach to initial therapy: When to start therapy?

Chronic Myelogenous Leukemia, An Issue of Hematology/Oncology Clinics of North America

  • 1st Edition
  • Volume 25-5
  • November 29, 2011
  • Daniel DeAngelo
  • English
  • Hardback
    9 7 8 - 1 - 4 3 7 7 - 2 5 3 0 - 8
Dr. DeAngelo has assembled top experts to write state-of-the art reviews on the management of chronic myelogenous leukemia. Some of the articles that will be of most interest to readers include: Hurdles Toward a Cure for CML: The CML Stem Cell; The biology of CML progression: Who, what, where, and why?; Chronic Myeloid Leukemia – Mechanisms of Resistance and Treatment; BCR-ABL mutations in CML; Selection of therapy: Rational Decisions Based on Molecular Events; Chronic myelogenous leukemia: Role of stem cell transplant in the Imatinib era; Portal Vein Thrombosis and Budd Chiari Syndrome.